Moss, MD, R. B., F. Carleton, PhD, C. P. Lollo, PhD, and D. J. Carlo, PhD. “An Open-Label, Randomized, Single-Dose, Two-Period, Two-Treatment Crossover Bioavailability Study Comparing 5 mg/0.5 ML of Intramuscular Naloxone Hydrochloride to 2 mg/0.4 ML Intramuscular Naloxone Hydrochloride Autoinjector in Healthy Subjects”. Journal of Opioid Management, vol. 16, no. 3, May 2020, pp. 209-14, doi:10.5055/jom.2020.0569.